SB Seredenin, TA Antipova, MV Voronin, SY Kurchashova, AN Kuimov: Interaction of afobazole with sigma1-receptors. In: Bulletin of experimental biology and medicine. 148. Jahrgang, Nr.1, 2009, S.42–4, doi:10.1007/s10517-009-0624-x, PMID 19902093.
drugfuture.com
Fabomotizole hydrochloride, in: Martindale: The Complete Drug Reference, 38th Edition, Pharmaceutical Press, London 2014. S. 1073.
nih.gov
ncbi.nlm.nih.gov
GG Neznamov, SA Siuniakov, DV Chumakov, VK Bochkarev, SB Seredenin: Clinical study of the selective anxiolytic agent afobazol. In: Eksperimental'naia i klinicheskaia farmakologiia. 64. Jahrgang, Nr.2, 2001, S.15–9, PMID 11548440.
IV Silkina, TC Gan'shina, SB Seredin, RS Mirzoian: Gabaergic mechanism of cerebrovascular and neuroprotective effects of afobazole and picamilon. In: Eksperimental'naia i klinicheskaia farmakologiia. 68. Jahrgang, Nr.1, 2005, S.20–4, PMID 15786959.
SB Seredin, DS Melkumian, EA Val'dman, MA Iarkova, TC Seredina, MV Voronin, AS Lapitskaia: Effects of afobazole on the BDNF content in brain structures of inbred mice with different phenotypes of emotional stress reaction. In: Eksperimental'naia i klinicheskaia farmakologiia. 69. Jahrgang, Nr.3, 2006, S.3–6, PMID 16878488.
TA Antipova, DS Sapozhnikova, LIu Bakhtina, SB Seredenin: Selective anxiolytic afobazole increases the content of BDNF and NGF in cultured hippocampal HT-22 line neurons. In: Eksperimental'naia i klinicheskaia farmakologiia. 72. Jahrgang, Nr.1, 2009, S.12–4, PMID 19334503.
SB Seredenin, TA Antipova, MV Voronin, SY Kurchashova, AN Kuimov: Interaction of afobazole with sigma1-receptors. In: Bulletin of experimental biology and medicine. 148. Jahrgang, Nr.1, 2009, S.42–4, doi:10.1007/s10517-009-0624-x, PMID 19902093.
VE Medvedev, AP Trosnova, AV Dobrovol'skiĭ: Psychopharmacotherapy of anxiety disorders in patients with cardio-vascular diseases: the use of aphobazole. In: Zh Nevrol Psikhiatr Im S S Korsakova. 107. Jahrgang, Nr.7, 2007, S.25–9, PMID 18379478.
